Publications by authors named "Thomas Bastholm Olesen"

Claim this Profile
N
NaF-PET/CT imaging of atherosclerosis in type 2 diabetes: Associations with sex and history of cardiovascular events in a 2-year follow-up study.
Reza Piri, Jacob Volmer Stidsen, Jens Steen Nielsen, Jan Erik Henriksen, Reimar Wernich Thomsen, Thomas Bastholm Olesen

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of moderate to vigorous physical activity on systemic vascular resistance in Danish adults with recently diagnosed type 2 diabetes: a cross-sectional study.
Son Bao Nguyen, Thomas Bastholm Olesen, Sidsel Louise Domazet, Sofie Frigaard Kristoffersen, Jens Steen Nielsen

J Hum Hypertens· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer in women with previous gestational diabetes: a nationwide register-based cohort study.
Maria Hornstrup Christensen, Christina Anne Vinter, Thomas Bastholm Olesen, Maria Houborg Petersen, Ellen Aagaard Nohr

Breast Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure responses to testosterone therapy are amplified by hematocrit levels in opioid-induced androgen deficiency: a double-blind, randomized, placebo-controlled trial.
Thomas Bastholm Olesen, Dorte Glintborg, Frederik Jøhnk, Michael Hecht Olsen, Marianne Skovsager Andersen

J Hypertens· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Terminal Pro-Brain Type Natriuretic Peptide Predicts Cardiovascular Events Independently of Arterial Stiffness, Assessed By Carotid-to-Femoral Pulse Wave Velocity, in Apparently Healthy Subjects.
Charles Edward Frary, Marie Kofoed Blicher, Thomas Bastholm Olesen, Manan Pareek, Julie K K Vishram-Nielsen

Heart Lung Circ· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Education Level on Weight Loss in a Primary Care-Anchored eHealth Lifestyle Coaching Program in Denmark: A Randomized Controlled Trial.
Luma Shahin, Thomas Bastholm Olesen, Michael Hecht Olsen, Ditte Hjorth Laursen, Jeanette Reffstrup Christensen

Nutrients· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal microvascular markers in type 2 diabetes subphenotypes and latent autoimmune diabetes of adults.
Frederik N Pedersen, Jacob V Stidsen, Martin N Rasmussen, Henning-Beck Nielsen, Jan Erik Henriksen, Thomas Bastholm Olesen

Acta Ophthalmol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of age and sex on the prognostic importance of traditional cardiovascular risk factors, selected circulating biomarkers and other markers of subclinical cardiovascular damage.
Thomas Bastholm Olesen, Manan Pareek, Julie K K Vishram-Nielsen, Michael Hecht Olsen

Curr Opin Cardiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agreement Between Clinically Measured Weight and Self-reported Weight Among Patients With Type 2 Diabetes Through an mHealth Lifestyle Coaching Program in Denmark: Secondary Analysis of a Randomized Controlled Trial.
Albi Imeraj, Thomas Bastholm Olesen, Ditte Hjorth Laursen, Jens Søndergaard, Carl Joakim Brandt

JMIR Form Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Weight Loss in a Primary Care-Anchored eHealth Lifestyle Coaching Program: Randomized Controlled Trial.
Laura Hesseldal, Jeanette Reffstrup Christensen, Thomas Bastholm Olesen, Michael Hecht Olsen, Pernille Ravn Jakobsen

J Med Internet Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes.
Jacob Volmer Stidsen, Diana Hedevang Christensen, Jan Erik Henriksen, Kurt Højlund, Michael Hecht Olsen, Thomas Bastholm Olesen

Eur J Endocrinol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent autoimmune hypophysitis treated with rituximab: a case report.
Maria Kruse, Thomas Bastholm Olesen, Ljubo Markovic, Dorte Glintborg, Marianne Skovsager Andersen

J Med Case Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive vs. standard blood pressure control and vascular procedures: insights from the Systolic Blood Pressure Intervention Trial (SPRINT).
Maria Lukács Krogager, Manan Pareek, Kristian Hay Kragholm, Christina Byrne, Muthiah Vaduganathan, Thomas Bastholm Olesen

Eur Heart J Cardiovasc Pharmacother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention Trial.
Johanna Maria Christina Frary, Manan Pareek, Christina Byrne, Muthiah Vaduganathan, Tor Biering-Sørensen, Thomas Bastholm Olesen

Eur Heart J Cardiovasc Pharmacother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
Muthiah Vaduganathan, Manan Pareek, Anna M D Kristensen, Tor Biering-Sørensen, Christina Byrne, Thomas Bastholm Olesen

Eur J Heart Fail· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial.
Christina Byrne, Manan Pareek, Muthiah Vaduganathan, Tor Biering-Sørensen, Arman Qamar, Thomas Bastholm Olesen

Eur Heart J Cardiovasc Pharmacother· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort.
Charles Edward Frary, Marie Kofoed Blicher, Thomas Bastholm Olesen, Jacob Volmer Stidsen, Sara Vikström Greve

Eur J Prev Cardiol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the specialist supervised individualised multifactorial treatment of new clinically diagnosed type 2 diabetes in general practice (IDA): a prospective controlled multicentre open-label intervention study.
Jacob Volmer Stidsen, Jens Steen Nielsen, Jan Erik Henriksen, Søren Gunnar Friborg, Reimar Wernich Thomsen, Thomas Bastholm Olesen

BMJ Open· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT study.
Daniel Gordin, Fadl Elmula M Fadl Elmula, Bert Andersson, Anders Gottsäter, Johan Elf, Thomas Bastholm Olesen

Blood Press· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Thomas Bastholm Olesen

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Thomas Bastholm Olesen

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases.
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Thomas Bastholm Olesen

Dan Med J· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis